Smith Chas P & Associates PA Cpas reduced its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.2% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 359,598 shares of the compa

Merck & Co., Inc. (NYSE:MRK - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twenty-five brokerages that are presently covering the stock, MarketBeat.com reports. Eight analysts have rated the stock with a hold rating and seventeen have issued a buy rating on

Talon Private Wealth LLC acquired a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 7,741 shares of the company

The Manufacturers Life Insurance Company boosted its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 12.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,073,176 shares of the company

Corient Private Wealth LP lowered its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,391,313 shares of the company

IPG Investment Advisors LLC cut its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 82.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,702 shares of the company

Representative Maria Elvira Salazar (Republican-Florida) recently bought shares of Merck & Co., Inc. (NYSE:MRK). In a filing disclosed on September 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Merck & Co., Inc. stock on August 19th. The trade occurred in the

At the close on September 10, 2026, Merck & Co. stock finished at USD 144.71 on the NYSE, down 1.9%

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Merck & Co., Inc. (NYSE:MRK) Stock Price Down 1.9% - Here

HSBC increased their target price on Merck & Co., Inc. from $150.00 to $172.00 and gave the company a "buy" rating in a research note on Thursday.

Integrated Wealth Concepts LLC increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 12.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 128,068 share

National Pension Service boosted its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 0.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,791,782 shares of the company

Blue Edge Capital LLC acquired a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 11,499 shares of the company

Archford Capital Strategies LLC lessened its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 20.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 27,354 shares of the company

At the close on September 9, 2026, Merck & Co. stock finished the Nasdaq session virtually unchanged